Hybridan Small Cap Feast: 26 March 2026
The clinical stage biotech company has received its first milestone royalty payment of $0.5m from Ligand Pharmaceuticals Incorporated.
127 Views
Treatt PLC - Hybridan Small Cap Feast: 24/07/2025
In accordance with the Nasdaq Listing Rules, Argo intends to request a hearing before a Nasdaq Hearings Panel.
216 Views
Treatt - Termination of coverage
Edison Investment Research is terminating coverage on Kinarus Therapeutics (KNRS), Numis Corporation (NUM), EMIS Group (EMIS), Pixium Vision (PIX)...
467 Views
Treatt - Return to growth in FY23
Treatt’s FY23 results show a significantly improved y-o-y operating performance, delivering revenue and profit growth alongside record cash...
259 Views
Treatt - FY23 profits in line despite headwinds
Treatt’s FY23 trading update demonstrated a resilient performance despite the tougher trading environment towards the end of the year. Revenue...
455 Views